634193-30-9 Usage
Molecular structure
1-Pyrrolidineheptanoic acid, 2-[(1E,3R)-4,4-difluoro-3-hydroxy-4-phenyl-1-butenyl]-5-oxo-, 1-methylethyl ester, (2R)is an ester derivative of 1-Pyrrolidineheptanoic acid with a fluorine-substituted phenyl group and a hydroxyl group on the butenyl side chain.
Stereochemistry
The compound has a 2R stereochemistry, which greatly influences its interactions with biological targets.
Anti-inflammatory properties
As an ester derivative of 1-Pyrrolidineheptanoic acid, it inherits its anti-inflammatory properties.
Neuroprotective properties
The parent compound, 1-Pyrrolidineheptanoic acid, is known for its neuroprotective properties, which may be retained or enhanced in this derivative.
Potential pharmaceutical applications
Due to its unique structure and biological activity, 1-Pyrrolidineheptanoic acid,
2-[(1E,3R)-4,4-difluoro-3-hydroxy-4-phenyl-1-butenyl]-5-oxo-,
1-methylethyl ester, (2R)- has potential pharmaceutical applications that require further research to fully understand.
Further research needed
The specific biological activity and pharmacological uses of 1-Pyrrolidineheptanoic acid,
2-[(1E,3R)-4,4-difluoro-3-hydroxy-4-phenyl-1-butenyl]-5-oxo-,
1-methylethyl ester, (2R)- are not yet fully understood and require additional investigation.
Check Digit Verification of cas no
The CAS Registry Mumber 634193-30-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,4,1,9 and 3 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 634193-30:
(8*6)+(7*3)+(6*4)+(5*1)+(4*9)+(3*3)+(2*3)+(1*0)=149
149 % 10 = 9
So 634193-30-9 is a valid CAS Registry Number.
634193-30-9Relevant academic research and scientific papers
1,5-DISTRIBUTED PYRROLID-2-ONE DERIVATIVES FOR USE AS EP4 RECEPTOR AGONISTS IN THE TREATMENT OF EYE DISEASES SUCH AS GLAUCOMA
-
Page 47, (2008/06/13)
This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors of formula (I), their use or a formulation thereof in the treatment of glaucoma and other conditions which are related to elevated intraocular pressure in the eye of the patient.
